Target type: biologicalprocess
The covalent attachment of a lipid group to the carboxy-terminus of a protein. [GOC:jl]
C-terminal protein lipidation is a post-translational modification process that involves the attachment of a lipid molecule to the C-terminus of a protein. This modification plays a crucial role in various cellular processes, including protein targeting, membrane association, and signal transduction.
The process typically begins with the recognition of a specific C-terminal sequence by a lipid transferase enzyme. These enzymes, also known as translocases, catalyze the transfer of a lipid molecule from a donor lipid to the protein substrate. The lipid molecule can be a fatty acid, such as palmitate or myristate, or a prenyl group, such as farnesyl or geranylgeranyl.
The attachment of the lipid molecule to the protein occurs through a covalent bond. This bond can be formed via a thioester linkage (for fatty acylation), a thioether linkage (for prenylation), or an amide linkage (for myristoylation).
Once lipidated, the protein can undergo various fates. It may be targeted to specific cellular membranes, such as the plasma membrane, the endoplasmic reticulum, or the Golgi apparatus. This targeting is mediated by the lipid moiety, which interacts with the lipid bilayer of the membrane.
Alternatively, the lipidation may promote protein-protein interactions, facilitating the formation of signaling complexes or protein assemblies. The lipid moiety can serve as a docking site for other proteins, enabling them to interact and regulate cellular functions.
Overall, C-terminal protein lipidation is a highly regulated process that plays a pivotal role in cellular function. It is involved in a wide range of biological processes, including membrane trafficking, signal transduction, and protein-protein interactions. The specific lipid modification and the C-terminal sequence targeted are often highly specific and contribute to the diverse functions of lipidated proteins.'
"
Protein | Definition | Taxonomy |
---|---|---|
Cysteine protease ATG4B | A cysteine protease ATG4B that is encoded in the genome of human. [PRO:DNx, UniProtKB:Q9Y4P1] | Homo sapiens (human) |
Ubiquitin-like modifier-activating enzyme ATG7 | A ubiquitin-like modifier-activating enzyme ATG7 that is encoded in the genome of human. [PRO:DNx, UniProtKB:O95352] | Homo sapiens (human) |
Cysteine protease ATG4A | A cysteine protease ATG4A that is encoded in the genome of human. [PRO:DNx, UniProtKB:Q8WYN0] | Homo sapiens (human) |
Compound | Definition | Classes | Roles |
---|---|---|---|
aurintricarboxylic acid | aurintricarboxylic acid : A member of the class of quinomethanes that is 3-methylidene-6-oxocyclohexa-1,4-diene-1-carboxylic acid in which the methylidene hydrogens are replaced by 4-carboxy-3-hydroxyphenyl groups. The trisodium salt is the biological stain 'chrome violet CG' while the triammonium salt is 'aluminon'. Aurintricarboxylic Acid: A dye which inhibits protein biosynthesis at the initial stages. The ammonium salt (aluminon) is a reagent for the colorimetric estimation of aluminum in water, foods, and tissues. | monohydroxybenzoic acid; quinomethanes; tricarboxylic acid | fluorochrome; histological dye; insulin-like growth factor receptor 1 antagonist |
hypericin | |||
tioconazole | 1-{2-[(2-chloro-3-thienyl)methoxy]-2-(2,4-dichlorophenyl)ethyl}imidazole : A member of the class of imidazoles that comprises 2-(2,4-dichlorophenyl)ethylimidazole carrying an additional (2-chloro-3-thienyl)methoxy substituent at position 2. tioconazole : A racemate comprising equimolar amounts of (R)- and (S)-tioconazole. | dichlorobenzene; ether; imidazoles; thiophenes | |
zpck | ZPCK: alkylates histidine residue at active center of bovine chymotrypsin | ||
n-(4-methoxybenzyl)-n'-(5-nitro-1,3-thiazol-2-yl)urea | N-(4-methoxybenzyl)-N'-(5-nitro-1,3-thiazol-2-yl)urea: structure in first source | ||
benzoylacrylic acid | benzoylacrylic acid: structure in first source | ||
nsc185058 | NSC185058: an ATG4B antagonist | ||
ellagic acid | catechols; cyclic ketone; lactone; organic heterotetracyclic compound; polyphenol | antioxidant; EC 1.14.18.1 (tyrosinase) inhibitor; EC 2.3.1.5 (arylamine N-acetyltransferase) inhibitor; EC 2.4.1.1 (glycogen phosphorylase) inhibitor; EC 2.5.1.18 (glutathione transferase) inhibitor; EC 2.7.1.127 (inositol-trisphosphate 3-kinase) inhibitor; EC 2.7.1.151 (inositol-polyphosphate multikinase) inhibitor; EC 2.7.4.6 (nucleoside-diphosphate kinase) inhibitor; EC 2.7.7.7 (DNA-directed DNA polymerase) inhibitor; EC 5.99.1.2 (DNA topoisomerase) inhibitor; EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor; food additive; fungal metabolite; geroprotector; plant metabolite; skin lightening agent | |
benzyloxycarbonyl-phe-ala-fluormethylketone | cathepsin B inhibitor : A cysteine protease inhibitor which inhibits cathepsin B (EC 3.4.22.1). | ||
3-(4-octadecyl)benzoylacrylic acid | |||
pevonedistat | pevonedistat : A pyrrolopyrimidine that is 7H-pyrrolo[2,3-d]pyrimidine which is substituted by a (1S)-2,3-dihydro-1H-inden-1-ylnitrilo group at position 4 and by a (1S,3S,4S)-3-hydroxy-4-[(sulfamoyloxy)methyl]cyclopentyl group at position 7. It is a potent and selective NEDD8-activating enzyme inhibitor with an IC50 of 4.7 nM, and currently under clinical investigation for the treatment of acute myeloid leukemia (AML) and myelodysplastic syndromes. pevonedistat: a potent and selective inhibitor of NAE (NEDD8-activating enzyme) | cyclopentanols; indanes; pyrrolopyrimidine; secondary amino compound; sulfamidate | antineoplastic agent; apoptosis inducer |